Clinical Trial

Future Innovations in Novel Detection of Heart Failure FIND-HF

Study acronym: FIND-HF
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Heart failure (HF) is increasingly common and associated with excess morbidity, mortality and healthcare costs. New medications are now available which can alter the disease trajectory and reduce clinical events. However, many cases of HF remain undetected until presentation with more advanced symptoms, often requiring hospitalisation. Earlier identification and treatment of HF could reduce downstream healthcare impact, but predicting HF incidence is challenging due to the complexity and varying course of HF. The investigators will use routinely collected hospital-linked primary care data and focus on the use of artificial intelligence methods to develop and validate a prediction model for incident HF. Using clinical factors readily accessible in primary care, the investigators will provide a method for the identification of individuals in the community who are at risk of HF, as well as when incident HF will occur in those at risk, thus accelerating research assessing technologies for the improvement of risk prediction, and the targeting of high-risk individuals for preventive measures and screening.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-02; most recent amendment 2025-03-25.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-03-25
Trial Details
NCT Number NCT05756127
Lead Sponsor University of Leeds
Collaborators: Japan Foundation for Aging and Health
Conditions Heart Failure
Enrollment 14,000 participants
Start Date 2023-04-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-30